Ex vivo characterization of polyclonal memory CD8+ T-cell responses to PRAME-specific peptides in patients with acute lymphoblastic leukemia and acute and chronic myeloid leukemia
Open Access
- 5 March 2009
- journal article
- Published by American Society of Hematology in Blood
- Vol. 113 (10) , 2245-2255
- https://doi.org/10.1182/blood-2008-03-144071
Abstract
Preferentially expressed antigen of melanoma (PRAME) is aberrantly expressed in hematologic malignancies and may be a useful target for immunotherapyKeywords
This publication has 59 references indexed in Scilit:
- Cytotoxic T lymphocytes directed to the preferentially expressed antigen of melanoma (PRAME) target chronic myeloid leukemiaBlood, 2008
- Hematopoietic stem cells and progenitors of chronic myeloid leukemia express leukemia-associated antigens: implications for the graft-versus-leukemia effect and peptide vaccine-based immunotherapyLeukemia, 2008
- Leukemia-associated antigen-specific T-cell responses following combined PR1 and WT1 peptide vaccination in patients with myeloid malignanciesBlood, 2008
- Graft-versus-leukemia effects associated with detectable Wilms tumor-1–specific T lymphocytes after allogeneic stem-cell transplantation for acute lymphoblastic leukemiaBlood, 2007
- High PR3 or ELA2 expression by CD34+ cells in advanced-phase chronic myeloid leukemia is associated with improved outcome following allogeneic stem cell transplantation and may improve PR1 peptide–driven graft-versus-leukemia effectsBlood, 2007
- Dysfunction and functional restoration of HCV-specific CD8 responses in chronic hepatitis C virus infectionHepatology, 2007
- CD8+T cells specific for cancer germline gene antigens are found in many patients with multiple myeloma, and their frequency correlates with disease burdenBlood, 2005
- Comparison of medulloblastoma and normal neural transcriptomes identifies a restricted set of activated genesOncogene, 2003
- Functional leukemia-associated antigen-specific memory CD8+ T cells exist in healthy individuals and in patients with chronic myelogenous leukemia before and after stem cell transplantationBlood, 2003
- Gene expression profiling predicts clinical outcome of breast cancerNature, 2002